Provider

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.  

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.

At the HIMSS AI Conference in San Diego, panelists discussed the steps needed to strategically incorporate AI into the healthcare setting.

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.

Updesh Dosanjh, practice leader of technology solutions for lQVIA, discusses ensuring fairness while using AI in clinical trials, the value of digital twins and the necessity of building and consistently adapting frameworks around AI use.  

Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.

Also, an ear health awareness app for indigenous children has received $1 million in funding from the Western Australia government.